SCHEMBL1355792

SCHEMBL1355792

COc1ccc(-n2ncc3cnc(Nc4ccc(NS(=O)(=O)C5CC5)cc4)nc32)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF2AK4 Q9P2K8 1/20 0.57
FLT3 P36888 1/20 0.50
TBK1 Q9UHD2 1/20 0.49
FGFR4 P22455 1/20 0.49
BRD4 O60885 12/20 0.48
JAK2 O60674 10/20 0.48
JAK1 P23458 2/20 0.48
BRD2 P25440 2/20 0.48
JAK3 P52333 2/20 0.48
BRD3 Q15059 2/20 0.48
BRDT Q58F21 2/20 0.48
PRKDC P78527 1/20 0.46
CDK4 P11802 1/20 0.45
CCND1 P24385 1/20 0.45
CCND2 P30279 1/20 0.45
CCND3 P30281 1/20 0.45
MAPK9 P45984 1/20 0.44
AURKA O14965 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1355988 0.87 FLT3 (0.64) EIF2AK4FLT3TBK1FGFR4JAK2
SCHEMBL1356098 0.83 EIF2AK4 (0.62) EIF2AK4FLT3TBK1FGFR4JAK2
SCHEMBL1355845 0.83 EIF2AK4 (0.60) EIF2AK4FLT3TBK1FGFR4JAK2
SCHEMBL1355679 0.82 FGFR4 (0.56) EIF2AK4FLT3TBK1FGFR4BRD4
SCHEMBL1353780 0.81 EIF2AK4 (0.60) EIF2AK4FLT3TBK1FGFR4JAK2
SCHEMBL1355752 0.81 EIF2AK4 (0.62) EIF2AK4TBK1FGFR4CDK4CCND1
SCHEMBL1356186 0.80 EIF2AK4 (0.67) EIF2AK4FLT3TBK1JAK2JAK3
SCHEMBL1356007 0.80 EIF2AK4 (0.67) EIF2AK4FLT3TBK1JAK2JAK3
SCHEMBL1355170 0.80 EIF2AK4 (0.61) EIF2AK4TBK1FGFR4CDK4CCND1
SCHEMBL1353760 0.80 EGFR (0.65) EIF2AK4TBK1FGFR4BRD4CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281821-A9 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2011-11-17 US claimed
US-20100249067-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2010-09-30 US claimed
US-20110281821-A9 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2011-11-17 US disclosed
US-20100249067-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249067-A1 Modulators of Mitotic Kinases BUB1, BUB1B, CDK1 EIF2AK4 791/4885FLT3 766/4885TBK1 1295/4885
US-20110281821-A9 Modulators of Mitotic Kinases BUB1, BUB1B, CDK1 EIF2AK4 791/4885FLT3 766/4885TBK1 1295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.